SIBN SI-BONE, Inc.

Nasdaq si-bone.com


$ 14.83 $ -0.32 (-2.11 %)    

Friday, 31-Oct-2025 15:59:55 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 14.83
$ 15.14
$ 14.05 x 10
$ 15.90 x 500
$ 14.73 - $ 15.31
$ 11.70 - $ 20.05
289,151
na
639.78M
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 03-02-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 03-10-2021 12-31-2020 10-K
20 11-03-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 03-11-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-29-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-buy-on-si-bone-lowers-price-target-to-20

Truist Securities analyst David Rescott maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $22 to $20.

 cantor-fitzgerald-reiterates-overweight-on-si-bone-maintains-25-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.

 si-bone-raises-fy2025-sales-guidance-from-193500m-197500m-to-195000m-198000m-vs-195834m-est

SI-BONE (NASDAQ:SIBN) raises FY2025 sales outlook from $193.500 million-$197.500 million to $195.000 million-$198.000 million v...

 si-bone-q2-eps-014-beats-019-estimate-sales-48630m-beat-48112m-estimate

SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 24...

 truist-securities-maintains-buy-on-si-bone-raises-price-target-to-22

Truist Securities analyst Samuel Brodovsky maintains SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $20 t...

 cantor-fitzgerald-reiterates-overweight-on-si-bone-maintains-25-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.

 needham-reiterates-buy-on-si-bone-maintains-24-price-target

Needham analyst David Saxon reiterates SI-BONE (NASDAQ:SIBN) with a Buy and maintains $24 price target.

 citizens-capital-markets-reiterates-market-outperform-on-si-bone-maintains-32-price-target

Citizens Capital Markets analyst David Turkaly reiterates SI-BONE (NASDAQ:SIBN) with a Market Outperform and maintains $32 p...

 truist-securities-reiterates-buy-on-si-bone-raises-price-target-to-22

Truist Securities analyst Samuel Brodovsky reiterates SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $18 ...

 cantor-fitzgerald-reiterates-overweight-on-si-bone-maintains-25-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.

 needham-maintains-buy-on-si-bone-raises-price-target-to-24

Needham analyst David Saxon maintains SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $20 to $24.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION